Edward T Mathers - Net Worth and Insider Trading

Edward T Mathers Net Worth

The estimated net worth of Edward T Mathers is at least $257 Million dollars as of 2024-12-26. Edward T Mathers is the 10% Owner of Savara Inc and owns about 24,471,264 shares of Savara Inc (SVRA) stock worth over $79 Million. Edward T Mathers is the Director, 10% Owner of MBX Biosciences Inc and owns about 3,614,486 shares of MBX Biosciences Inc (MBX) stock worth over $77 Million. Edward T Mathers is also the 10% Owner of Monte Rosa Therapeutics Inc and owns about 7,692,298 shares of Monte Rosa Therapeutics Inc (GLUE) stock worth over $56 Million. Besides these, Edward T Mathers also holds Korro Bio Inc (KRRO) . Details can be seen in Edward T Mathers's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Edward T Mathers has not made any transactions after 2024-09-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Edward T Mathers

Edward T Mathers Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Edward T Mathers owns 15 companies in total, including Inozyme Pharma Inc (INZY) , Akouos Inc (AKUS) , and Rhythm Pharmaceuticals Inc (RYTM) among others .

Click here to see the complete history of Edward T Mathers’s form 4 insider trades.

Insider Ownership Summary of Edward T Mathers

Ticker	Comapny	Transaction Date	Type of Owner
INZY	Inozyme Pharma Inc	2020-07-23	director
AKUS	Akouos Inc	2020-06-25	director
RYTM	Rhythm Pharmaceuticals Inc	2017-10-04	director
		2019-05-07	director
		2019-07-17	director
		2016-06-29	director
		2020-04-02	director
		2018-07-25	director
		2023-07-17	10 percent owner
		2021-04-08	director
		2021-06-24	10 percent owner
		2021-06-28	10 percent owner
		2022-06-08	director
		2023-01-01	director
		2024-04-22	10 percent owner

Edward T Mathers Latest Holdings Summary

Edward T Mathers currently owns a total of 4 stocks. Among these stocks, Edward T Mathers owns 24,471,264 shares of Savara Inc (SVRA) as of July 17, 2023, with a value of $79 Million and a weighting of 30.8%. Edward T Mathers owns 3,614,486 shares of MBX Biosciences Inc (MBX) as of September 16, 2024, with a value of $77 Million and a weighting of 29.82%. Edward T Mathers also owns 7,692,298 shares of Monte Rosa Therapeutics Inc (GLUE) as of June 28, 2021, with a value of $56 Million and a weighting of 21.61%. The other 1 stocks Korro Bio Inc (KRRO) have a combined weighting of 17.77% among all his current holdings.

Latest Holdings of Edward T Mathers

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
SVRA	Savara Inc	2023-07-17	24,471,264	3.24	79,164,539
MBX	MBX Biosciences Inc	2024-09-16	3,614,486	21.20	76,627,103
GLUE	Monte Rosa Therapeutics Inc	2021-06-28	7,692,298	7.22	55,538,392
KRRO	Korro Bio Inc	2024-04-22	1,090,793	41.86	45,660,595

Holding Weightings of Edward T Mathers

Edward T Mathers Form 4 Trading Tracker

According to the SEC Form 4 filings, Edward T Mathers has made a total of 1 transactions in Savara Inc (SVRA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Savara Inc is the acquisition of 333,333 shares on July 17, 2023, which cost Edward T Mathers around $999,999.

According to the SEC Form 4 filings, Edward T Mathers has made a total of 1 transactions in MBX Biosciences Inc (MBX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in MBX Biosciences Inc is the acquisition of 500,000 shares on September 16, 2024, which cost Edward T Mathers around $8 Million.

According to the SEC Form 4 filings, Edward T Mathers has made a total of 1 transactions in Monte Rosa Therapeutics Inc (GLUE) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Monte Rosa Therapeutics Inc is the acquisition of 1,050,000 shares on June 28, 2021, which cost Edward T Mathers around $20 Million.

More details on Edward T Mathers's insider transactions can be found in the Insider Trading History of Edward T Mathers table.

Insider Trading History of Edward T Mathers

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Edward T Mathers Trading Performance

GuruFocus tracks the stock performance after each of Edward T Mathers's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Edward T Mathers is -1.36%. GuruFocus also compares Edward T Mathers's trading performance to market benchmark return within the same time period. The performance of stocks bought by Edward T Mathers within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Edward T Mathers's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Edward T Mathers

Average Return

Average return per transaction

Outperforming Transactions

1 out of 2 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	3.75
Relative Return to S&P 500(%)	1.54

Edward T Mathers Ownership Network

Ownership Network List of Edward T Mathers

No Data

Ownership Network Relation of Edward T Mathers

Edward T Mathers Owned Company Details

What does Inozyme Pharma Inc do?

Who are the key executives at Inozyme Pharma Inc?

Edward T Mathers is the director of Inozyme Pharma Inc. Other key executives at Inozyme Pharma Inc include director & 10 percent owner Robert Lorne Hopfner , COO Matthew Winton , and See Remarks Henric Bjorn Bjarke .

Inozyme Pharma Inc (INZY) Insider Trades Summary

Over the past 18 months, Edward T Mathers made no insider transaction in Inozyme Pharma Inc (INZY). Other recent insider transactions involving Inozyme Pharma Inc (INZY) include a net purchase of 833,333 shares made by Pivotal Bioventure Partners Fund I G.p., L.p. , a net purchase of 833,333 shares made by Robert Lorne Hopfner , and a net sale of 7,523 shares made by Douglas A Treco .

In summary, during the past 3 months, insiders sold 0 shares of Inozyme Pharma Inc (INZY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,523 shares of Inozyme Pharma Inc (INZY) were sold and 1,666,666 shares were bought by its insiders, resulting in a net purchase of 1,659,143 shares.

Inozyme Pharma Inc (INZY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Inozyme Pharma Inc Insider Transactions

No Available Data

What does Akouos Inc do?

Who are the key executives at Akouos Inc?

Edward T Mathers is the director of Akouos Inc. Other key executives at Akouos Inc include 10 percent owner Kearny Acquisition Corp , 10 percent owner Lilly Eli & Co , and Chief Operating Officer Jennifer Anne Wellman .

Akouos Inc (AKUS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Akouos Inc (AKUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Akouos Inc (AKUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Akouos Inc (AKUS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Akouos Inc Insider Transactions

No Available Data

What does Rhythm Pharmaceuticals Inc do?

Who are the key executives at Rhythm Pharmaceuticals Inc?

Edward T Mathers is the director of Rhythm Pharmaceuticals Inc. Other key executives at Rhythm Pharmaceuticals Inc include EVP & Head of North America Jennifer Chien , Chief Technical Officer Joseph Shulman , and Chief Human Resources Officer Pamela J. Cramer .

Rhythm Pharmaceuticals Inc (RYTM) Insider Trades Summary

Over the past 18 months, Edward T Mathers made no insider transaction in Rhythm Pharmaceuticals Inc (RYTM). Other recent insider transactions involving Rhythm Pharmaceuticals Inc (RYTM) include a net sale of 184,943 shares made by Joseph Shulman , a net sale of 145,755 shares made by Jennifer Chien , and a net sale of 85,162 shares made by Pamela J. Cramer .

In summary, during the past 3 months, insiders sold 89,517 shares of Rhythm Pharmaceuticals Inc (RYTM) in total and bought 0 shares, with a net sale of 89,517 shares. During the past 18 months, 672,183 shares of Rhythm Pharmaceuticals Inc (RYTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 672,183 shares.

Rhythm Pharmaceuticals Inc (RYTM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Rhythm Pharmaceuticals Inc Insider Transactions

No Available Data

What does Trevi Therapeutics Inc do?

Who are the key executives at Trevi Therapeutics Inc?

Edward T Mathers is the director of Trevi Therapeutics Inc. Other key executives at Trevi Therapeutics Inc include director & 10 percent owner & See Remarks Jennifer L Good , director & 10 percent owner David P Meeker , and 10 percent owner & Chief Medical Officer Thomas Sciascia .

Trevi Therapeutics Inc (TRVI) Insider Trades Summary

Over the past 18 months, Edward T Mathers made no insider transaction in Trevi Therapeutics Inc (TRVI). Other recent insider transactions involving Trevi Therapeutics Inc (TRVI) include a net sale of 7,215 shares made by Lisa Delfini , a net sale of 90,795 shares made by Jennifer L Good , and a net sale of 101,369 shares made by Thomas Sciascia .

In summary, during the past 3 months, insiders sold 0 shares of Trevi Therapeutics Inc (TRVI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 203,934 shares of Trevi Therapeutics Inc (TRVI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 203,934 shares.

Trevi Therapeutics Inc (TRVI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Trevi Therapeutics Inc Insider Transactions

No Available Data

What does Mirum Pharmaceuticals Inc do?

Who are the key executives at Mirum Pharmaceuticals Inc?

Edward T Mathers is the director of Mirum Pharmaceuticals Inc. Other key executives at Mirum Pharmaceuticals Inc include SVP & Global Controller Jolanda Howe , director & 10 percent owner Patrick J Heron , and Chief Scientific Officer Pamela Vig .

Mirum Pharmaceuticals Inc (MIRM) Insider Trades Summary

Over the past 18 months, Edward T Mathers made no insider transaction in Mirum Pharmaceuticals Inc (MIRM). Other recent insider transactions involving Mirum Pharmaceuticals Inc (MIRM) include a net sale of 11,012 shares made by Jolanda Howe , a net purchase of 162,308 shares made by Patrick J Heron , and a net sale of 34,606 shares made by Pamela Vig .

In summary, during the past 3 months, insiders sold 2,500 shares of Mirum Pharmaceuticals Inc (MIRM) in total and bought 0 shares, with a net sale of 2,500 shares. During the past 18 months, 93,742 shares of Mirum Pharmaceuticals Inc (MIRM) were sold and 176,308 shares were bought by its insiders, resulting in a net purchase of 82,566 shares.

Mirum Pharmaceuticals Inc (MIRM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Mirum Pharmaceuticals Inc Insider Transactions

No Available Data

What does Synlogic Inc do?

Who are the key executives at Synlogic Inc?

Edward T Mathers is the director of Synlogic Inc. Other key executives at Synlogic Inc include Chief Operating Officer Antoine Awad , Chief Financial Officer Michael Vangsted Jensen , and Chief Medical Officer Aoife Brennan .

Synlogic Inc (SYBX) Insider Trades Summary

Over the past 18 months, Edward T Mathers made no insider transaction in Synlogic Inc (SYBX). Other recent insider transactions involving Synlogic Inc (SYBX) include a net sale of 267 shares made by , and a net sale of 372 shares made by Antoine Awad .

In summary, during the past 3 months, insiders sold 79 shares of Synlogic Inc (SYBX) in total and bought 0 shares, with a net sale of 79 shares. During the past 18 months, 639 shares of Synlogic Inc (SYBX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 639 shares.

Synlogic Inc (SYBX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Synlogic Inc Insider Transactions

No Available Data

What does Ra Pharmaceuticals Inc do?

Who are the key executives at Ra Pharmaceuticals Inc?

Edward T Mathers is the director of Ra Pharmaceuticals Inc. Other key executives at Ra Pharmaceuticals Inc include Executive VP and CFO David Charles Lubner , director & 10 percent owner Rajeev M. Shah , and 10 percent owner New Enterprise Associates 13 Lp .

Ra Pharmaceuticals Inc (RARX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Ra Pharmaceuticals Inc (RARX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ra Pharmaceuticals Inc (RARX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ra Pharmaceuticals Inc (RARX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ra Pharmaceuticals Inc Insider Transactions

No Available Data

What does Liquidia Corp do?

Who are the key executives at Liquidia Corp?

Edward T Mathers is the director of Liquidia Corp. Other key executives at Liquidia Corp include SVP & Commercial Scott Moomaw , Chief Financial Officer Michael Kaseta , and General Counsel Russell Schundler .

Liquidia Corp (LQDA) Insider Trades Summary

Over the past 18 months, Edward T Mathers made no insider transaction in Liquidia Corp (LQDA). Other recent insider transactions involving Liquidia Corp (LQDA) include a net sale of 13,758 shares made by Jason Adair , a net sale of 14,011 shares made by Scott Moomaw , and a net sale of 33,720 shares made by Rajeev Saggar .

In summary, during the past 3 months, insiders sold 26,053 shares of Liquidia Corp (LQDA) in total and bought 0 shares, with a net sale of 26,053 shares. During the past 18 months, 309,661 shares of Liquidia Corp (LQDA) were sold and 2,023,391 shares were bought by its insiders, resulting in a net purchase of 1,713,730 shares.

Liquidia Corp (LQDA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Liquidia Corp Insider Transactions

No Available Data

What does Savara Inc do?

Who are the key executives at Savara Inc?

Edward T Mathers is the 10 percent owner of Savara Inc. Other key executives at Savara Inc include Chief Financial Officer David L Lowrance , 10 percent owner Rick Yang , and 10 percent owner Scott D Sandell .

Savara Inc (SVRA) Insider Trades Summary

Over the past 18 months, Edward T Mathers made 1 insider transaction in Savara Inc (SVRA) with a net purchase of 333,333. Other recent insider transactions involving Savara Inc (SVRA) include a net sale of 138,702 shares made by Matthew Pauls , a net sale of 35,000 shares made by David L Lowrance , and a net purchase of 333,333 shares made by Rick Yang .

In summary, during the past 3 months, insiders sold 87,702 shares of Savara Inc (SVRA) in total and bought 120,000 shares, with a net purchase of 32,298 shares. During the past 18 months, 275,545 shares of Savara Inc (SVRA) were sold and 3,453,330 shares were bought by its insiders, resulting in a net purchase of 3,177,785 shares.

Savara Inc (SVRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Savara Inc Insider Transactions

No Available Data

What does Reneo Pharmaceuticals Inc do?

Who are the key executives at Reneo Pharmaceuticals Inc?

Edward T Mathers is the director of Reneo Pharmaceuticals Inc. Other key executives at Reneo Pharmaceuticals Inc include Chief Development Officer Ashley Hall , 10 percent owner Novo Holdings A/s , and Senior VP & Corporate Operation Michael Cruse .

Reneo Pharmaceuticals Inc (RPHM) Insider Trades Summary

Over the past 18 months, Edward T Mathers made no insider transaction in Reneo Pharmaceuticals Inc (RPHM). Other recent insider transactions involving Reneo Pharmaceuticals Inc (RPHM) include a net purchase of 1,199,482 shares made by Braden Michael Leonard , and a net sale of 15,625 shares made by Ashley Hall .

In summary, during the past 3 months, insiders sold 0 shares of Reneo Pharmaceuticals Inc (RPHM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,563 shares of Reneo Pharmaceuticals Inc (RPHM) were sold and 119,948 shares were bought by its insiders, resulting in a net purchase of 118,386 shares.

Reneo Pharmaceuticals Inc (RPHM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Reneo Pharmaceuticals Inc Insider Transactions

No Available Data

What does NeueHealth Inc do?

Who are the key executives at NeueHealth Inc?

Edward T Mathers is the 10 percent owner of NeueHealth Inc. Other key executives at NeueHealth Inc include director & CEO and President Mikan George Lawrence Iii , Chief Financial Officer Jay Matushak , and Chief Accounting Officer Jeffrey J Scherman .

NeueHealth Inc (NEUE) Insider Trades Summary

Over the past 18 months, Edward T Mathers made no insider transaction in NeueHealth Inc (NEUE). Other recent insider transactions involving NeueHealth Inc (NEUE) include a net sale of 3,494 shares made by Jay Matushak , a net sale of 73,542 shares made by Mikan George Lawrence Iii , and a net sale of 1,436 shares made by Jeffrey J Scherman .

In summary, during the past 3 months, insiders sold 16,890 shares of NeueHealth Inc (NEUE) in total and bought 0 shares, with a net sale of 16,890 shares. During the past 18 months, 82,553 shares of NeueHealth Inc (NEUE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 82,553 shares.

NeueHealth Inc (NEUE)'s detailed insider trading history can be found in Insider Trading Tracker table.

NeueHealth Inc Insider Transactions

No Available Data

What does Monte Rosa Therapeutics Inc do?

Who are the key executives at Monte Rosa Therapeutics Inc?

Edward T Mathers is the 10 percent owner of Monte Rosa Therapeutics Inc. Other key executives at Monte Rosa Therapeutics Inc include 10 percent owner Versant Venture Capital Vi, L.p. , Principal Accounting Officer Edmund Dunn , and General Counsel Philip Nickson .

Monte Rosa Therapeutics Inc (GLUE) Insider Trades Summary

Over the past 18 months, Edward T Mathers made no insider transaction in Monte Rosa Therapeutics Inc (GLUE). Other recent insider transactions involving Monte Rosa Therapeutics Inc (GLUE) include a net sale of 1,857,674 shares made by Versant Venture Capital Vi, L.p. , and a net sale of 2,817 shares made by Edmund Dunn .

In summary, during the past 3 months, insiders sold 157,895 shares of Monte Rosa Therapeutics Inc (GLUE) in total and bought 0 shares, with a net sale of 157,895 shares. During the past 18 months, 1,860,491 shares of Monte Rosa Therapeutics Inc (GLUE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,860,491 shares.

Monte Rosa Therapeutics Inc (GLUE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Monte Rosa Therapeutics Inc Insider Transactions

No Available Data

What does Senti Biosciences Inc do?

Who are the key executives at Senti Biosciences Inc?

Edward T Mathers is the director of Senti Biosciences Inc. Other key executives at Senti Biosciences Inc include Chief Medical & Devt. Officer Kanya Rajangam , 10 percent owner Scott D Sandell , and 10 percent owner Bayer Us Holding Lp .

Senti Biosciences Inc (SNTI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Senti Biosciences Inc (SNTI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Senti Biosciences Inc (SNTI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Senti Biosciences Inc (SNTI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Senti Biosciences Inc Insider Transactions

No Available Data

What does ObsEva SA do?

Who are the key executives at ObsEva SA?

Edward T Mathers is the director of ObsEva SA. Other key executives at ObsEva SA include Chief Financial Officer William Michael Brown , and director & Chief Executive Officer Brian O'callaghan .

ObsEva SA (OBSEF) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ObsEva SA (OBSEF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ObsEva SA (OBSEF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ObsEva SA (OBSEF)'s detailed insider trading history can be found in Insider Trading Tracker table.

ObsEva SA Insider Transactions

No Available Data

What does Korro Bio Inc do?

Who are the key executives at Korro Bio Inc?

Edward T Mathers is the 10 percent owner of Korro Bio Inc. Other key executives at Korro Bio Inc include Chief Financial Officer Vineet Agarwal , 10 percent owner Scott D Sandell , and 10 percent owner New Enterprise Associates 17, L.p. .

Korro Bio Inc (KRRO) Insider Trades Summary

Over the past 18 months, Edward T Mathers made 1 insider transaction in Korro Bio Inc (KRRO) with a net purchase of 17,857. Other recent insider transactions involving Korro Bio Inc (KRRO) include a net sale of 11,016 shares made by Vineet Agarwal , a net sale of 2,124 shares made by David L. Lucchino , and a net purchase of 17,857 shares made by Scott D Sandell .

In summary, during the past 3 months, insiders sold 11,016 shares of Korro Bio Inc (KRRO) in total and bought 0 shares, with a net sale of 11,016 shares. During the past 18 months, 13,140 shares of Korro Bio Inc (KRRO) were sold and 178,570 shares were bought by its insiders, resulting in a net purchase of 165,430 shares.

Korro Bio Inc (KRRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Korro Bio Inc Insider Transactions

No Available Data

Edward T Mathers Mailing Address

Above is the net worth, insider trading, and ownership report for Edward T Mathers. You might contact Edward T Mathers via mailing address: C/o Medimmune, Inc., One Medimmune Way, Gaithersburg Md 20878.

Discussions on Edward T Mathers

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.